S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
IRON · Disc Medicine, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Disc Medicine Inc (IRON)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$75.96
-3.50
(-4.40%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$75.96
$75.95
$81.23
52-WEEK RANGE
$75.96
$40.00
$99.50
What's happening
- IRON is down 4.40% today, trading at $75.96. — Live quote
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-1.54 actual vs. $-1.78 estimated (+13.6%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 7
Buy 11
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (19 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
IRON
+0.09%
vs S&P 500
-12.69%
1-YEAR RETURN
IRON
-8.82%
vs S&P 500
-23.38%
6-MONTH RETURN
IRON
+14.44%
3-MONTH RETURN
IRON
+5.16%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-1.54
Est. $-1.78
BEAT +13.6%
2026-04-26 (Q1 2026)
$-1.65
Est. $-1.75
BEAT +5.6%
2026-01-26 (Q4 2025)
$-1.64
Est. $-1.78
BEAT +7.8%
2025-10-26 (Q3 2025)
$-1.77
Est. $-1.49
MISS -18.6%
Valuation Measures & Ratios
Enterprise Value4$2.88B
Forward P/E5—
PEG Ratio6-0.26
Price / Sales (TTM1)—
Price / Book74.34
EV4 / Revenue—
EV4 / EBITDA—
Profit Margin—
Operating Margin—
Return on Equity (ROE8)-37.17%
Return on Assets (ROA9)-33.65%
Avg Volume (3M)673,890
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $2.83B | $2.46B | $2.33B | $1.85B | $1.66B |
| P/E | -11.74 | -11.45 | -13.05 | -13.00 | -14.56 |
| Price/Book | 4.39 | 3.58 | 4.06 | 3.01 | 2.51 |
| EV/EBITDA | -10.58 | -10.08 | -10.98 | — | — |
| ROE | -37.35% | -31.25% | -31.09% | -23.17% | -17.26% |
| ROA | -32.73% | -28.68% | -28.27% | -21.39% | -16.07% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short7,270,420
Change from Prior Settlement+0.87%
% of Float—
Days to Cover (Short Ratio)12.79
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 4, filed 2026-10-21; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Trailing 52-week price return is -8.8%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on IRON
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Operating income | -$65.1M | -$69.5M | -$67.7M | -$61.4M | -$39.9M | -$32.9M | -$30.9M | -$31.5M |
| Net income | -$59.5M | -$63.5M | -$62.3M | -$55.2M | -$34.1M | -$26.6M | -$26.4M | -$26.9M |
| EPS (diluted) | $-1.54 | $-1.65 | $-1.77 | $-1.58 | $-1.02 | $-0.89 | $-1.03 | $-1.09 |
| EPS (basic) | $-1.54 | $-1.65 | $-1.77 | $-1.58 | $-1.02 | $-0.89 | $-1.03 | $-1.09 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $735.1M | $750.2M | $806.9M | $630.5M | $665.1M | $709.3M | $496.8M | $495.1M |
| Total liabilities | $90.9M | $61.8M | $67.1M | $57.1M | $50.9M | $48.9M | $53.2M | $27.2M |
| Stockholders' equity | $644.2M | $688.4M | $739.8M | $573.4M | $614.2M | $660.4M | $443.6M | $468.0M |
| Total current assets | $732.8M | $747.5M | $803.9M | $627.2M | $661.6M | $705.6M | $493.6M | $493.2M |
| Total current liabilities | $30.4M | $31.1M | $36.6M | $26.7M | $20.6M | $18.7M | $23.3M | $25.5M |
| Cash & equivalents | $98.7M | $88.9M | $91.1M | $140.7M | $127.3M | $122.7M | $192.4M | $192.6M |
| Marketable securities (current) | $619.1M | $641.2M | $700.0M | $475.3M | $522.6M | $572.0M | $297.4M | $294.7M |
| Property, plant & equipment | $980.0K | $1.1M | $1.2M | $1.2M | $1.3M | $1.4M | $751.0K | $79.0K |
| Other non-current assets | $496.0K | $721.0K | $726.0K | $840.0K | $840.0K | $839.0K | $838.0K | $236.0K |
| Accounts payable | $6.8M | $11.8M | $9.0M | $7.3M | $6.3M | $6.7M | $7.9M | $3.6M |
| Accrued liabilities | $8.9M | $6.8M | $15.6M | $11.1M | $6.2M | $4.1M | $8.1M | $5.5M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Long-term debt | $59.3M | $29.4M | $29.2M | $28.9M | $28.7M | $28.5M | $28.3M | — |
| Common stock & paid-in capital | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K |
| Retained earnings | -$633.2M | -$573.7M | -$510.2M | -$449.7M | -$387.3M | -$332.1M | -$298.0M | -$268.5M |
| Accumulated other comprehensive income (loss) | -$1.6M | -$571.0K | $965.0K | $718.0K | $273.0K | $535.0K | $289.0K | $741.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$44.2M | -$62.2M | -$43.3M | -$47.8M | -$47.9M | -$41.4M | -$27.6M | -$17.4M |
| Investing cash flow | $21.6M | $58.3M | -$222.9M | $49.5M | $51.7M | -$272.6M | -$1.4M | -$71.1M |
| Financing cash flow | $32.3M | $1.7M | $216.7M | $11.6M | $892.0K | $244.3M | $28.8M | $426.0K |
| Free cash flow | -$44.2M | -$62.2M | -$43.3M | -$47.8M | -$48.0M | -$42.2M | -$28.0M | -$17.4M |
| Capital expenditures | $0 | $0 | $20.0K | $26.0K | $36.0K | $851.0K | $449.0K | -$8.0K |
| Depreciation & amortization | $90.0K | $89.0K | $89.0K | $87.0K | $85.0K | $20.0K | $9.0K | $11.0K |
| Share-based compensation | $13.9M | $11.9M | $10.0M | $9.5M | $8.4M | $6.4M | $4.3M | $4.3M |
| Deferred income taxes | — | — | $0 | — | — | — | — | — |
| Change in accounts payable | -$4.9M | $2.7M | $1.8M | $918.0K | -$321.0K | -$1.3M | $4.4M | -$1.0M |
| Purchases of investments | $92.7M | $93.8M | $358.3M | $85.4M | $58.6M | $347.2M | $72.8M | $94.1M |
| Sales/maturities of investments | $114.4M | $152.1M | $135.4M | $135.0M | $110.4M | $75.5M | $71.8M | $23.0M |
| Other investing activities | — | — | — | — | — | — | — | — |
| Debt issued | $30.0M | — | $0 | — | $0 | — | $29.0M | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating income | -$236.0M | -$129.7M | -$91.1M | -$47.5M | -$30.9M |
| Net income | -$212.2M | -$109.4M | -$76.4M | -$46.8M | -$36.0M |
| EPS (diluted) | $-6.01 | $-3.96 | $-3.42 | $-45.05 | $-40.95 |
| EPS (basic) | $-6.01 | $-3.96 | $-3.42 | $-45.05 | $-40.95 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $806.9M | $496.8M | $368.0M | $200.2M | $92.4M |
| Total liabilities | $67.1M | $53.2M | $22.9M | $23.6M | $14.8M |
| Stockholders' equity | $739.8M | $443.6M | $345.1M | $176.6M | -$64.2M |
| Total current assets | $803.9M | $493.6M | $365.7M | $198.5M | $90.5M |
| Total current liabilities | $36.6M | $23.3M | $21.4M | $22.6M | $13.4M |
| Cash & equivalents | $91.1M | $192.4M | $360.4M | $194.6M | $88.0M |
| Marketable securities (current) | $700.0M | $297.4M | $0 | — | — |
| Property, plant & equipment | $1.2M | $751.0K | $170.0K | $168.0K | $106.0K |
| Other non-current assets | $726.0K | $838.0K | $234.0K | $116.0K | $180.0K |
| Accounts payable | $9.0M | $7.9M | $12.6M | $16.2M | $2.6M |
| Accrued liabilities | $15.6M | $8.1M | $6.2M | $6.1M | $4.1M |
| Short-term debt | — | — | — | — | — |
| Long-term debt | $29.2M | $28.3M | $0 | — | — |
| Common stock & paid-in capital | $4.0K | $3.0K | $2.0K | $2.0K | $0 |
| Retained earnings | -$510.2M | -$298.0M | -$188.6M | -$112.2M | -$65.4M |
| Accumulated other comprehensive income (loss) | $965.0K | $289.0K | $0 | — | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$180.4M | -$93.9M | -$73.5M | -$42.3M | -$27.5M |
| Investing cash flow | -$394.3M | -$292.3M | -$89.0K | -$151.0K | -$68.0K |
| Financing cash flow | $473.4M | $218.3M | $239.4M | $149.0M | $89.9M |
| Free cash flow | -$181.3M | -$94.4M | -$73.6M | -$42.4M | -$27.6M |
| Capital expenditures | $933.0K | $505.0K | $89.0K | $151.0K | $68.0K |
| Depreciation & amortization | $281.0K | $156.0K | $100.0K | $89.0K | $32.0K |
| Share-based compensation | $34.3M | $16.8M | $5.5M | $2.1M | $507.0K |
| Deferred income taxes | $0 | — | — | — | — |
| Change in accounts payable | $1.1M | -$4.7M | -$3.7M | $526.0K | $1.3M |
| Purchases of investments | $849.6M | $386.6M | $0 | — | — |
| Sales/maturities of investments | $456.2M | $94.8M | $0 | — | — |
| Debt issued | $0 | $29.0M | $0 | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding IRON as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-04-13 to 2026-09-15
Recent transactions
- Insiders have net sold 236,933 shares over the last 182 days, across 0 purchases and 39 sales.
- Most recent: Quisel John D (Chief Executive Officer) — Option exercise of 36,000 shares on 2026-09-15.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)236,933 sh(39 txns)
Net Shares-236,933
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Quisel John D | Chief Executive Officer | Option exercise | 2026-09-15 | 36,000 |
| Bitterman Kevin | Reporting person | Option exercise | 2026-09-11 | 7,136 |
| Yu Jonathan Yen-Wen | Chief Operating Officer | Option exercise | 2026-08-25 | 8,796 |
| Khara Rahul | Chief Legal Officer | Option exercise | 2026-08-06 | 5,000 |
| Franchi Jean M. | Chief Financial Officer | Open market sale | 2026-04-14 | 6,257 |
| Savage William Jacob | Chief Medical Officer | Open market sale | 2026-04-13 | 3,531 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-15 | Quisel John D | Chief Executive Officer | Option exercise | 36,000 | $1.01 |
| 2026-09-11 | Bitterman Kevin | Reporting person | Option exercise | 7,136 | $45.69 |
| 2026-09-11 | Bitterman Kevin | Reporting person | Option exercise | 10,000 | $38.85 |
| 2026-09-11 | Bitterman Kevin | Reporting person | Option exercise | 10,000 | $50.86 |
| 2026-09-11 | Bitterman Kevin | Reporting person | Open market sale | 27,136 | $70.11 |
| 2026-09-04 | Bitterman Kevin | Reporting person | Open market sale | 912 | $79.96 |
| 2026-09-04 | Bitterman Kevin | Reporting person | Open market sale | 759 | $79.96 |
| 2026-09-04 | Bitterman Kevin | Reporting person | Open market sale | 18 | $79.96 |
| 2026-09-03 | Bitterman Kevin | Reporting person | Open market sale | 2,810 | $79.98 |
| 2026-09-03 | Bitterman Kevin | Reporting person | Open market sale | 2,339 | $79.98 |
| 2026-09-03 | Bitterman Kevin | Reporting person | Open market sale | 54 | $79.98 |
| 2026-09-02 | Bitterman Kevin | Reporting person | Open market sale | 26,542 | $80.17 |
| 2026-09-02 | Bitterman Kevin | Reporting person | Open market sale | 22,090 | $80.17 |
| 2026-09-02 | Bitterman Kevin | Reporting person | Open market sale | 511 | $80.17 |
| 2026-09-02 | Bitterman Kevin | Reporting person | Open market sale | 10 | $80.98 |
| 2026-09-02 | Bitterman Kevin | Reporting person | Open market sale | 9 | $80.98 |
| 2026-09-02 | Bitterman Kevin | Reporting person | Open market sale | 2 | $80.98 |
| 2026-09-01 | Bitterman Kevin | Reporting person | Open market sale | 70 | $79.95 |
| 2026-09-01 | Bitterman Kevin | Reporting person | Open market sale | 58 | $79.95 |
| 2026-09-01 | Bitterman Kevin | Reporting person | Open market sale | 1 | $79.95 |
| 2026-08-25 | Yu Jonathan Yen-Wen | Chief Operating Officer | Option exercise | 8,796 | $13.50 |
| 2026-08-25 | Yu Jonathan Yen-Wen | Chief Operating Officer | Open market sale | 8,796 | $83.12 |
| 2026-08-24 | Yu Jonathan Yen-Wen | Chief Operating Officer | Option exercise | 300 | $13.50 |
| 2026-08-24 | Yu Jonathan Yen-Wen | Chief Operating Officer | Open market sale | 300 | $82.53 |
| 2026-08-17 | Quisel John D | Chief Executive Officer | Option exercise | 33,000 | $13.50 |
| 2026-08-17 | Quisel John D | Chief Executive Officer | Open market sale | 8,400 | $78.11 |
| 2026-08-17 | Quisel John D | Chief Executive Officer | Open market sale | 12,712 | $79.20 |
| 2026-08-17 | Quisel John D | Chief Executive Officer | Open market sale | 11,888 | $79.84 |
| 2026-08-12 | Yu Jonathan Yen-Wen | Chief Operating Officer | Option exercise | 804 | $13.50 |
| 2026-08-12 | Yu Jonathan Yen-Wen | Chief Operating Officer | Open market sale | 804 | $82.64 |
| 2026-08-06 | Khara Rahul | Chief Legal Officer | Option exercise | 5,000 | $14.69 |
| 2026-08-06 | Khara Rahul | Chief Legal Officer | Open market sale | 5,000 | $80.00 |
| 2026-07-13 | Quisel John D | Chief Executive Officer | Option exercise | 25,584 | $9.86 |
| 2026-07-13 | Quisel John D | Chief Executive Officer | Option exercise | 7,416 | $13.50 |
| 2026-07-13 | Quisel John D | Chief Executive Officer | Open market sale | 9,704 | $74.27 |
| 2026-07-13 | Quisel John D | Chief Executive Officer | Open market sale | 16,896 | $74.95 |
| 2026-07-13 | Quisel John D | Chief Executive Officer | Open market sale | 6,400 | $76.05 |
| 2026-07-07 | Yu Jonathan Yen-Wen | Chief Operating Officer | Option exercise | 100 | $13.50 |
| 2026-07-07 | Yu Jonathan Yen-Wen | Chief Operating Officer | Open market sale | 100 | $82.50 |
| 2026-06-29 | Khara Rahul | Chief Legal Officer | Option exercise | 1,649 | $14.69 |
| 2026-06-29 | Khara Rahul | Chief Legal Officer | Open market sale | 1,649 | $75.00 |
| 2026-06-26 | Khara Rahul | Chief Legal Officer | Option exercise | 851 | $14.69 |
| 2026-06-26 | Khara Rahul | Chief Legal Officer | Open market sale | 851 | $75.00 |
| 2026-06-26 | Yu Jonathan Yen-Wen | Chief Operating Officer | Option exercise | 300 | $13.50 |
| 2026-06-26 | Yu Jonathan Yen-Wen | Chief Operating Officer | Open market sale | 300 | $72.50 |
| 2026-06-22 | Yu Jonathan Yen-Wen | Chief Operating Officer | Option exercise | 9,700 | $13.50 |
| 2026-06-22 | Yu Jonathan Yen-Wen | Chief Operating Officer | Open market sale | 9,700 | $72.66 |
| 2026-06-18 | Khara Rahul | Chief Legal Officer | Option exercise | 7,500 | $14.69 |
| 2026-06-18 | Khara Rahul | Chief Legal Officer | Open market sale | 5,400 | $69.94 |
| 2026-06-18 | Khara Rahul | Chief Legal Officer | Open market sale | 1,600 | $70.73 |
| 2026-06-18 | Khara Rahul | Chief Legal Officer | Open market sale | 500 | $71.62 |
| 2026-06-18 | Quisel John D | Chief Executive Officer | Option exercise | 34,000 | $9.86 |
| 2026-06-18 | Quisel John D | Chief Executive Officer | Open market sale | 22,927 | $69.92 |
| 2026-06-18 | Quisel John D | Chief Executive Officer | Open market sale | 9,522 | $70.70 |
| 2026-06-18 | Quisel John D | Chief Executive Officer | Open market sale | 1,551 | $71.61 |
| 2026-06-16 | Yu Jonathan Yen-Wen | Chief Operating Officer | Option exercise | 5,261 | $9.86 |
| 2026-06-16 | Yu Jonathan Yen-Wen | Chief Operating Officer | Option exercise | 13,351 | $9.86 |
| 2026-06-16 | Yu Jonathan Yen-Wen | Chief Operating Officer | Open market sale | 11,651 | $68.76 |
| 2026-06-16 | Yu Jonathan Yen-Wen | Chief Operating Officer | Open market sale | 6,961 | $69.92 |
| 2026-04-14 | Franchi Jean M. | Chief Financial Officer | Open market sale | 6,257 | $69.24 |
Showing the most recent 60 transactions.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 04:26 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-21 | 4 | 2026-10-19 | View on SEC.gov → |
| 2026-10-19 | 8-K | 2026-10-19 | View on SEC.gov → |
| 2026-09-16 | 4 | 2026-09-15 | View on SEC.gov → |
| 2026-09-15 | 4 | 2026-09-11 | View on SEC.gov → |
| 2026-09-10 | 8-K | 2026-09-09 | View on SEC.gov → |
| 2026-09-09 | 4 | 2026-09-04 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-08-26 | 4 | 2026-08-24 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-17 | View on SEC.gov → |
| 2026-08-14 | 4 | 2026-08-12 | View on SEC.gov → |
| 2026-08-07 | 4 | 2026-08-06 | View on SEC.gov → |
| 2026-07-30 | 10-Q | 2026-06-30 | View on SEC.gov → |
Recent news
Headlines about IRON (Disc Medicine, Inc.). Links open the publisher — we don’t host full articles.
-
Fortescue shares hit 16-month low as Q1 iron ore shipments miss estimates
Yahoo Finance Singapore · 2026-10-22 -
Disc Medicine (NASDAQ:IRON) Director Sells 10,994 Shares of Stock
MarketBeat · 2026-10-21 -
Insider Selling: Disc Medicine (NASDAQ:IRON) Director Sells $2,047,389.37 in Stock
MarketBeat · 2026-10-21 -
Disc Medicine (NASDAQ:IRON) Director Sells $424,694.40 in Stock
MarketBeat · 2026-10-21 -
Disc Medicine, Inc. (IRON) Discusses Topline Results of APOLLO Phase III Trial of Bitopertin in EPP - Slideshow
Seeking Alpha · 2026-10-21 -
Disc Medicine director Bitterman sells $3.35m in shares By Investing.com
Investing.com Australia · 2026-10-21 -
Planned sales of 41,825 shares in Disc Medicine (IRON) spanned nine transactions.
Stock Titan · 2026-10-21 -
Jefferies raises Disc Medicine stock price target on drug opportunity
Investing.com · 2026-10-21
No headlines in this category right now — try “All”.